News
- Author:
- Nancy A. Melville
Publish date: November 20, 2023
Key misconceptions among smokers with type 2 diabetes that can prevent cessation include concerns about post-cessation weight gain, the influence o...
News
- Author:
- Nancy A. Melville
Publish date: November 15, 2023
“This self-administered medication allows patients to be more independent and can even travel since it is not dependent on an infusion center.”
News
- Author:
- Nancy A. Melville
Publish date: November 15, 2023
Chemotherapy-related mobility declines in CIPN survivors are likely due to both neuromuscular and executive dysfunction.
News
- Author:
- Nancy A. Melville
Publish date: November 8, 2023
A new subcutaneous injectable showed efficacy and tolerability in patients with chronic inflammatory demyelinating polyneuropathy.
News
- Author:
- Nancy A. Melville
Publish date: November 7, 2023
“What’s really striking, and in my mind the most impressive, is that when you follow these patients out 3 or 4 years ... you see there is this bump...
News
- Author:
- Nancy A. Melville
Publish date: November 1, 2023
With toripalimab and radiotherapy, progression-free survival at 2 years is high for extranodal NK/T-cell lymphoma in those who respond poorly to ch...
News
- Author:
- Nancy A. Melville
Publish date: October 26, 2023
Mortality rates from early-stage ocular MALT lymphoma are low, with relapse rates lowered by radiation therapy.
News
- Author:
- Nancy A. Melville
Publish date: October 11, 2023
The implication is that nonsurgical options such as radiofrequency ablation may be appropriate for more patients than realized.
News
- Author:
- Nancy A. Melville
Publish date: October 6, 2023
“I would characterize the trends in our data as being potentially suggestive or hypothesis generating – not conclusive.”
News
- Author:
- Nancy A. Melville
Publish date: October 4, 2023
“While we can never assume that [the events occurred] because the blood-thinner therapy was held, the timing within 48 hours is certainly very susp...
News
- Author:
- Nancy A. Melville
Publish date: October 2, 2023
"The very long median overall survival in the study's neoadjuvant group is quite remarkable for a group of patients who used to have a very poor pr...
News
- Author:
- Nancy A. Melville
Publish date: September 28, 2023
“A typical indication is fracture detection, not in terms of replacing expert radiologists or orthopedists but rather in terms of supporting those ...
News
- Author:
- Nancy A. Melville
Publish date: September 28, 2023
Among clinicians and their patients, widespread myths about sickle cell disease can stand in the way of adequate treatment.
News
- Author:
- Nancy A. Melville
Publish date: September 27, 2023
A Nigerian-American hematologist draws on her experience living with sickle cell disease to encourage child patients and advise colleagues.
News
- Author:
- Nancy A. Melville
Publish date: September 26, 2023
Given the array of potential obstacles to endocrine therapy adherence, improving long-term use may be equally complex.
